2024
DOI: 10.1007/s10787-024-01475-2
|View full text |Cite
|
Sign up to set email alerts
|

Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient

Rosa María García-Álvarez,
Maruxa Zapata-Cachafeiro,
Irene Visos-Varela
et al.

Abstract: Objectives To assess the impact of prior chronic treatment with angiotensin-converting enzyme inhibitors (ACEIs)/ angiotensin-receptor blockers (ARBs), both as a group and by active ingredient, on severity (risk of hospitalization and mortality), progression of and susceptibility to COVID-19. Methods We conducted a multiple population-based case–control study in Galicia (north-west Spain). The study data were sourced from medical, administrative and clinic… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 35 publications
0
0
0
Order By: Relevance